Inducible types of cyclooxygenase and nitric oxide synthase in adaptive cytoprotection in rat stomachs

H Yamamoto1, A Tanaka, T Kunikata

  • 1Department of Pharmacology & Experimental Therapeutics, Kyoto Pharmaceutical University, Misasagi, Yamashina, Japan.

Insights

Taurocholate (TC) protects rat stomachs from acid damage via adaptive cytoprotection. Early protection involves cyclooxygenase-1 (COX-1) and prostaglandins (PGs), while later protection involves inducible nitric oxide synthase (iNOS) and nitric oxide (NO).

Area of Science:

  • Gastroenterology
  • Pharmacology
  • Cell Biology

Background:

  • Gastric mucosal injury is a significant health concern.
  • Adaptive cytoprotection mechanisms in the stomach are not fully understood.
  • Taurocholate (TC) has shown potential in protecting the gastric mucosa.

Purpose of the Study:

  • To investigate the roles of cyclooxygenases (COX-1, COX-2) and nitric oxide synthases (nNOS, iNOS) in taurocholate (TC)-induced adaptive cytoprotection in rat stomachs.
  • To elucidate the temporal mechanisms underlying TC-mediated gastric protection against acid-induced injury.

Main Methods:

  • Rat stomachs were subjected to 0.6 N HCl-induced hemorrhagic damage.
  • Pretreatment with TC was administered at different time points (0.5 h and 5 h before HCl).
  • Pharmacological inhibitors (indomethacin, NS-398, L-NAME, aminoguanidine) were used to block specific enzymes.
  • Gastric mucosal prostaglandin E2 (PGE2) and luminal NOx output were measured.
  • Messenger RNA (mRNA) expression for COX-2 and iNOS was analyzed.

Main Results:

  • TC pretreatment significantly protected rat stomachs against HCl-induced damage for over 5 hours.
  • Early protection (0.5 h post-TC) was primarily mediated by COX-1/prostaglandins (PGs), inhibited by indomethacin.
  • Later protection (5 h post-TC) involved both PGs (via COX-1 and COX-2) and nitric oxide (NO) (via iNOS), as indicated by inhibition with indomethacin, NS-398, L-NAME, and aminoguanidine.
  • TC increased PGE2 and NOx levels, and induced COX-2 and iNOS mRNA expression in a time-dependent manner.

Conclusions:

  • TC induces significant adaptive cytoprotection in the rat stomach against acute acid injury.
  • The protective mechanism is time-dependent, with early phase mediated by COX-1/PGs and the later phase involving iNOS/NO and COX-1/COX-2/PGs.
  • Understanding these distinct temporal mechanisms can inform therapeutic strategies for gastric protection.

Related Concept Videos

Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...